Surgalign is a healthcare equipment & supplies business based in the US. Surgalign shares (SRGA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.01 – the same closing value as a week prior. Surgalign employs 217 staff and has a trailing 12-month revenue of around $78.1 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.01 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $0.67 |
| 200-day moving average | $1.69 |
| Wall St. target price | $2.25 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-8.12 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.011 from 2023-09-01
| 1 week (2024-10-09) | N/A |
|---|---|
| 1 month (2024-09-16) | N/A |
| 3 months (2024-07-16) | N/A |
| 6 months (2024-04-16) | N/A |
| 1 year (2023-10-16) | N/A |
|---|---|
| 2 years (2022-10-20) | -99.65% |
| 3 years (2021-10-20) | 1.05 |
| 5 years (2019-10-18) | 2.68 |
| Revenue TTM | $78.1 million |
|---|---|
| Gross profit TTM | $40.3 million |
| Return on assets TTM | -34.94% |
| Return on equity TTM | -1497.02% |
| Profit margin | -64.63% |
| Book value | $-2.08 |
| Market Capitalization | $1.7 million |
TTM: trailing 12 months
We're not expecting Surgalign to pay a dividend over the next 12 months.
Surgalign's shares were split on a 1:30 basis on 16 May 2022 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Surgalign shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Surgalign shares which in turn could have impacted Surgalign's share price.
Over the last 12 months, Surgalign's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surgalign's is 1.7961. This would suggest that Surgalign's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Surgalign Holdings, Inc. , a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2. 0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.